Skip to content

Sarcopenia and Physical Performance in Hemodialysis Patients

Assessment of Sarcopenia, Physical Performance and Cognitive Function in Hemodialysis Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04669184
Enrollment
26
Registered
2020-12-16
Start date
2021-01-01
Completion date
2022-03-01
Last updated
2020-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Kidney Disease

Keywords

sarcopenia, pain, physical performance

Brief summary

Many systems such as the cardiovascular, pulmonary, musculoskeletal, hematological, immunological, gastrointestinal, central nervous system are affected due to decreased kidney function. The aim of this study was to investigate the relationship between physical performance and sarcopenia, peripheral muscle strength, activities of daily living, cognitive functions, physical activity level, fragility, pain in hemodialysis patients.

Detailed description

A high prevalence of sarcopenia has been reported in end stage kidney disease. The incidence of sarcopenia increases with age. Muscle atrophy is caused by an imbalance between the anabolic and catabolic processes in chronic kidney disease. Sarcopenia and physical inactivity progress synergistically. Decreased physical performance is associated with sarcopenia. In hemodialysis patients, daily physical activity level and physical performance decrease. Cognitive impairment is common in chronic kidney disease. Uremic toxins can cause a decrease in cognitive function. One of the most important problems associated with hemodialysis is pain and pain negatively affects functional capacity and quality of life.

Interventions

None listed

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Having been diagnosed with end stage kidney disease * Receiving hemodialysis for more than 3 months * Being clinically stable * Volunteering to participate in the research

Exclusion criteria

* Having an orthopedic disease that may affect functional capacity * Having cardiac event in the past 3 months

Design outcomes

Primary

MeasureTime frameDescription
Sarcopenia5 minutesSarcopenia will be evaluated using SARC-F questionnaire. For SARC-F, a total score of ≥ 4 indicates sarcopenia.
Physical performance will be evaluated using Short physical performance battery.10 minutesThe total score of Short physical performance battery ranges from 0 to 12.
Physical performance will be evaluated using 1 minute sit to stand test.5 minutes1 minute sit to stand test, the maximum number of repetitions within the established time was recorded
Pain level5 minutesPain will be evaluated using Short-form McGill Pain questionnaire

Secondary

MeasureTime frameDescription
Peripheral muscle strength5 minutesKnee extensor and hand grip strength will be evaluated using dynamometer.
Activities of daily living10 minutesActivities of daily living will be evaluated using Barthel Index for Activities of Daily Living.The total score is100 and higher scores mean a better outcome.
Cognitive function10 minutesCognitive function will be evaluated using Standardized Mini-Mental State Examination. The test is a 30-point screening tool. Higher scores mean a better outcome.
Physical activity level5 minutesPhysical activity level will be evaluated using International Physical Activity Questionnaire-Short Form
Fragility5 minutesFragility will be evaluated using the five Fried frailty criteria (unintentional weight loss, exhaustion, weakness, slowness, low physical activity). The total score is interpreted as follows: 0 non-frail, 1-2 pre-frail and 3-5 frail

Contacts

Primary ContactMerve Firat
mervefirat@hacettepe.edu.tr+903123051576

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026